Exclusive Insights: Dana-Farber Researchers Uncover Factors Influencing Cell Therapy Efficacy in Leukemia
Boston's Dana-Farber Cancer Institute has made a significant advancement in understanding the complex landscape of acute myeloid leukemia (AML) treatment, ...